trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT2 receptor family (original ) (raw )Synthesis and Serotonin Receptor Affinities of a Series of trans -2-(Indol-3-yl)cyclopropylamine Derivatives
David Nichols
Journal of Medicinal Chemistry, 1998
View PDFchevron_right
N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues
David Nichols
ACS chemical neuroscience, 2015
View PDFchevron_right
Cyclopropyl-tryptamine Analogues: Synthesis and Biological Evaluation as 5-HT 6 Receptor Ligands
János Sápi
ChemMedChem, 2013
View PDFchevron_right
Discovery of N-Substituted 2-Phenylcyclopropylmethylamines as Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists for Potential Use as Antipsychotic Medications
alan kozikowski
Journal of medicinal chemistry, 2017
View PDFchevron_right
Structure–Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor
SHUJIE WANG
Biomolecules & Therapeutics
View PDFchevron_right
Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents
Patrick Giguere , Oluseye Onajole
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Selective 5Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action
alan kozikowski
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: A Potent Serotonin 5-HT2A/2C Agonist
David Nichols
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: Definition of its binding profile using agonists, antagonists and inverse agonists
Adrian Newman-Tancredi
Naunyn-Schmiedeberg's Archives of Pharmacology, 1998
View PDFchevron_right
Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists
Thirumal Yempala
ACS omega, 2020
View PDFchevron_right
Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists
Thirumal Yempala
ACS Omega, 2020
View PDFchevron_right
Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT 1A Receptors
M. Kleven
View PDFchevron_right
2-Substituted Tryptamines: Agents with Selectivity for 5-HT 6 Serotonin Receptors ‖
Sandy J Hufeisen
Journal of Medicinal Chemistry, 2000
View PDFchevron_right
5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines
Bruce Cassels
PLOS ONE, 2019
View PDFchevron_right
New 5-Hydroxytryptamine1A Receptor Ligands Containing a Norbornene Nucleus: Synthesis and in Vitro Pharmacological Evaluation
Paola Massarelli
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Derivatives of cis-2-Amino-8-hydroxy-1-methyltetralin: Mixed 5-HT1A-Receptor Agonists and Dopamine D2-Receptor Antagonists
Tommy Lewander
Journal of Medicinal Chemistry, 1995
View PDFchevron_right
Dopamine/serotonin receptor ligands. Part 17: A cross-target SAR approach: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors
Christoph Enzensperger
Bioorganic & Medicinal Chemistry Letters, 2008
View PDFchevron_right
N -Methyl-5- tert -butyltryptamine: A Novel, Highly Potent 5-HT 1D Receptor Agonist
James Audia
Journal of Medicinal Chemistry, 1999
View PDFchevron_right
Research Letter: Structural Combination of Established 5-HT2A Receptor Ligands: New Aspects of the Binding Mode
Mikael Palner
Chemical Biology & Drug Design, 2010
View PDFchevron_right
C5-Substituted Derivatives of 5-OMe-BPAT: Synthesis and Interactions with Dopamine D2 and Serotonin 5-HT1A Receptors
Martin Tulp
Bioorganic & Medicinal Chemistry, 1999
View PDFchevron_right
Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT2 Receptors
A. Olma
PLoS ONE, 2013
View PDFchevron_right
Emerging Opportunities and Concerns for Drug Discovery at Serotonin 5- 5-HT 2B Receptors
eduardo dominguez medina
View PDFchevron_right
4-Aryl-Substituted 2,5-Dimethoxyphenethylamines: Synthesis and Serotonin 5-HT2AReceptor Affinities
David Nichols
Chemistry & Biodiversity, 2009
View PDFchevron_right
Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites
bellinda benhamu
Jcamd, 1998
View PDFchevron_right
Binding Properties of Dipropyltryptamine at the Human 5-HT1a Receptor
Ethan B Russo
Pharmacology, 2005
View PDFchevron_right
Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists
alan kozikowski
Journal of medicinal chemistry, 2016
View PDFchevron_right
Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist
Linda Liau
Pharmacology Biochemistry and Behavior, 1991
View PDFchevron_right
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models
William Wetsel
Journal of medicinal chemistry, 2016
View PDFchevron_right
New 5-HT1A receptor ligands containing a N′-cyanoisonicotinamidine nucleus: Synthesis and in vitro pharmacological evaluation
Paola Massarelli
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right